Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in Pediatric Intensive Care Unit. A Multicenter, Double-blind, Randomized Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2019
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Substance withdrawal syndrome
- Focus Therapeutic Use
- Acronyms TIP-15-01
- 23 Dec 2018 Planned End Date changed from 1 Mar 2020 to 1 Aug 2021.
- 23 Dec 2018 Planned primary completion date changed from 1 Mar 2020 to 1 Aug 2021.
- 31 Aug 2018 New trial record